Malin Life Sciences Holdings LTD is > 10% Shareholder of Poseida Therapeutics, Inc.. Currently has a direct ownership of 11.8 Million shares of PSTX, which is worth approximately $32.1 Million. The most recent transaction as insider was on Aug 08, 2022, when has been sold 2,150,000 shares (Common Stock) at a price of $3.5 per share, resulting in proceeds of $7,525,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.8M
0% 3M change
0% 12M change
Total Value Held $32.1 Million

Malin Life Sciences Holdings Ltd Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 08 2022
BUY
Open market or private purchase
$7,525,000 $3.5 p/Share
2,150,000 Added 15.37%
11,835,673 Common Stock
Dec 06 2021
BUY
Open market or private purchase
$12,613 $6.9 p/Share
1,828 Added 0.02%
9,685,673 Common Stock
Dec 02 2021
BUY
Open market or private purchase
$29,556 $6.88 p/Share
4,296 Added 0.04%
9,683,845 Common Stock
Dec 01 2021
BUY
Open market or private purchase
$125,800 $6.85 p/Share
18,365 Added 0.19%
9,679,549 Common Stock
Nov 30 2021
BUY
Open market or private purchase
$195,855 $6.85 p/Share
28,592 Added 0.3%
9,661,184 Common Stock
Nov 29 2021
BUY
Open market or private purchase
$76,183 $6.89 p/Share
11,057 Added 0.11%
9,632,592 Common Stock
Nov 26 2021
BUY
Open market or private purchase
$185,579 $6.81 p/Share
27,251 Added 0.28%
9,621,535 Common Stock
Nov 24 2021
BUY
Open market or private purchase
$7,262 $6.89 p/Share
1,054 Added 0.01%
9,594,284 Common Stock
Nov 23 2021
BUY
Open market or private purchase
$99,011 $6.77 p/Share
14,625 Added 0.15%
9,593,230 Common Stock
Nov 19 2021
BUY
Open market or private purchase
$82,614 $7.44 p/Share
11,104 Added 0.12%
9,578,605 Common Stock
Nov 18 2021
BUY
Open market or private purchase
$512,020 $7.18 p/Share
71,312 Added 0.74%
9,567,501 Common Stock
Nov 17 2021
BUY
Open market or private purchase
$2,021,569 $7.21 p/Share
280,384 Added 2.87%
9,496,189 Common Stock
Nov 16 2021
BUY
Open market or private purchase
$198,466 $7.17 p/Share
27,680 Added 0.3%
9,215,805 Common Stock
MLS

Malin Life Sciences Holdings LTD

> 10% Shareholder
Dublin, Ireland, L2

Track Institutional and Insider Activities on PSTX

Follow Poseida Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PSTX shares.

Notify only if

Insider Trading

Get notified when an Poseida Therapeutics, Inc. insider buys or sells PSTX shares.

Notify only if

News

Receive news related to Poseida Therapeutics, Inc.

Track Activities on PSTX